Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-07-28
1988-04-26
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702
Patent
active
047404990
ABSTRACT:
A method of prolonging or enhancing the bioactivity of atrial peptides is disclosed in which thiorphan or kelatorphan is administered contemporaneously with the administration of the atrial peptide.
REFERENCES:
patent: 4496544 (1985-01-01), Needleman
patent: 4513099 (1985-04-01), Roques et al.
Burnett et al., Am. J. Physiol. 247, F863-6 (1984).
Luft et al., J. Pharmacol. Exp. Ther. 236(2), 416-418 (1986).
Yandle et al., Life Sci. 38, 1827-1833 (1986).
Briggs et al., Chem. Absts. 101:184852 (1984).
Thibault et al., Chem. Absts. 101: 66823 (1984).
Tang et al., Chem. Absts. 102:1084 (1985).
Roques et al., Nature 288, 286-288 (1980).
Bouboutou et al., Life Sci. 35, 1023-30 (1984).
Fournie-Zaluski et al., J. Med. Chem. 28, 1158-69 (1985).
Kenny et al., Biochem. Soc. Trans. 13, 293-295 (1985).
Fulcher et al., Biochem. J. 203, 519-522 (1984).
Chemical Abstracts, vol. 105, No. 146991.
Meyer Scott J.
Monsanto Company
Phillips Delbert R.
Williams, Jr. James W.
LandOfFree
Method of enhancing the bioactivity of atrial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of enhancing the bioactivity of atrial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of enhancing the bioactivity of atrial peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819612